메뉴 건너뛰기




Volumn 25, Issue 23, 2004, Pages 2167-2168

Drug-eluting stents: Meta-analysis in diabetic patients [1]

Author keywords

[No Author keywords available]

Indexed keywords

DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG ELUTING STENT; FOLLOW UP; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; LETTER; MEDICAL RESEARCH; PRIORITY JOURNAL; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 9644267017     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2004.07.041     Document Type: Letter
Times cited : (72)

References (6)
  • 1
    • 3042711337 scopus 로고    scopus 로고
    • Drug-eluting stents: An early systematic review to inform policy
    • R.A. Hill, Y. Dündar, and A. Bakhai Drug-eluting stents: an early systematic review to inform policy Eur Heart J 25 2004 902 919
    • (2004) Eur Heart J , vol.25 , pp. 902-919
    • Hill, R.A.1    Dündar, Y.2    Bakhai, A.3
  • 2
    • 12144289144 scopus 로고    scopus 로고
    • Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease
    • V.M.G. Legrand, P.W Serruys, and F. Unger on behalf of the Arterial Revascularization Therapy Study (ARTS) Investigators Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease Circulation 109 2004 1114 1120
    • (2004) Circulation , vol.109 , pp. 1114-1120
    • Legrand, V.M.G.1    Serruys, P.W.2
  • 3
    • 1842590347 scopus 로고    scopus 로고
    • Meta-analysis of the effect of diabetes on restenosis rates among patients receiving coronary angioplasty stenting
    • J. Gilbert, J. Raboud, and B. Zinman Meta-analysis of the effect of diabetes on restenosis rates among patients receiving coronary angioplasty stenting Diabetes Care 27 2004 990 994
    • (2004) Diabetes Care , vol.27 , pp. 990-994
    • Gilbert, J.1    Raboud, J.2    Zinman, B.3
  • 4
    • 0038711003 scopus 로고    scopus 로고
    • New frontiers in cardiology. Drug-eluting stents (part I & part II)
    • J.E. Sousa, P.W. Serruys, and M.A. Costa New frontiers in cardiology. Drug-eluting stents (part I & part II) Circulation 107 2003 2274 2279 2383-2389
    • (2003) Circulation , vol.107 , pp. 2274-2279
    • Sousa, J.E.1    Serruys, P.W.2    Costa, M.A.3
  • 5
    • 2542453844 scopus 로고    scopus 로고
    • Impact of sirolimus eluting stents on outcome in diabetic patients. A SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy
    • I. Moussa, M.B. Leon, and D.S. Baim Impact of sirolimus eluting stents on outcome in diabetic patients. A SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy Circulation 109 2004 2273 2278
    • (2004) Circulation , vol.109 , pp. 2273-2278
    • Moussa, I.1    Leon, M.B.2    Baim, D.S.3
  • 6
    • 9144255404 scopus 로고    scopus 로고
    • Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real World". The Rapamycin Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) Registry
    • P.A. Lemos, P.W. Serruys, and R.T. van Domburg Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "Real World". The Rapamycin Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) Registry Circulation 109 2004 190 195
    • (2004) Circulation , vol.109 , pp. 190-195
    • Lemos, P.A.1    Serruys, P.W.2    Van Domburg, R.T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.